Company intelligence / Profile preview

Lifespan Technologies

Salt Lake City*, Utah, United Stateslifespantech.com ↗

Ownership: Private
Development stage: Commercial

Overview

Lifespan Technologies develops, manufactures, and sells direct carbohydrate detection solutions using ELISA technology. Their products are established commercial assays for detecting heparin, dextran, dermatan sulfate, heparan sulfate, etc., with advantages including high specificity/accuracy and rapid processing times. They also offer laboratory analysis services. No clinical trial results as these are diagnostics.

Therapeutic areas: Hematology
Modalities: ELISA kit (Enzyme-linked immunosorbent assay)Diagnostic assayBiologic
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Lifespan Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lifespan Technologies.

Explore the full profile